HOME › Press Releases › The Global Ophthalmology Devices and Drugs Market is expected to reach $52.6 billion by 2017
The Global Ophthalmology Devices and Drugs Market is expected to reach $52.6 billion by 2017
The “Ophthalmology Drugs & Devices Market (Contact Lens, OCT Scanner, IOL, Dry Eye, AMD, Glaucoma) Competitive Landscape & Global Forecasts To 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Browse 222 tables spread across 517 pages and the in-depth TOC on “Ophthalmology Drugs & Devices Market (Contact Lens, OCT Scanner, IOL, Dry Eye, AMD, Glaucoma) Competitive Landscape & Global Forecasts To 2017 ”
Early buyers will receive 10% customization on reports.
This report studies the global ophthalmology drugs and devices market, with forecast to 2017.
The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. However, lack of awareness of eye diseases hinders the growth of this market. The drugs market will grow at a slower pace mainly due to the combined effect of loss of patent protection for several drugs and drying pipeline. This market is also considered by formulation types, which include capsules, gels, eye drops, ointment, and eye solutions.
The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology drugs and devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. APAC is an unsaturated market, especially China and India, and these regions are expected to drive the growth of the overall ophthalmology market, mainly due to growing awareness of eye diseases and increasing disposable income.
The key players in the ophthalmology drugs market are Alcon (U.S.), Allergan, Inc. (U.S.),
Merck and Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Roche Holdings AG (Switzerland), and Santen Pharmaceutical Co., Ltd. (Japan). In the devices market, the prominent players are Abbott Medical Optics (U.S.), Alcon, Inc. (Switzerland), Bausch & Lomb, Inc. (U.S.), Carl Zeiss Meditec (Germany), Essilor International S.A. (France), Johnson & Johnson (U.S.), Nidek Co., Ltd. (Japan), and Topcon Corporation (Japan).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252